Clinical Trial

Post-market Clinical Follow-up (PMCF) Study of Safety and Performance of 502-01 AnGelHA 2

Recruiting
View on ClinicalTrials.gov →
Summary
Post-market clinical follow-up (PMCF) investigation to evaluate the performance and safety of AnGelHA 2 filler for the correction of moderate to severe wrinkles and folds and facial contour remodeling, in a routine clinical setting.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-04-16
Trial Details
NCT Number NCT07495865
Lead Sponsor Glyance
Conditions Wrinkles
Enrollment 87 participants
Start Date 2026-02-08
Primary Completion 2027-03-12 (estimated)
Study Completion 2027-03-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-28